Breaking News

Results support the ability of the test to not only identify hormonal therapy non-responders, but to predict their improved survival on chemotherapy.

A new analysis of immune cells in breast carcinomas and matched blood, breast, and lymph tissue uncovered phenotypic expansions in tumor immune cell populations.

The company plans to use the new funding to grow its suite of genomics applications to more than 50 in 2018.

The funding will help support the whole-genome and RNA sequencing of Alzheimer's disease patients to advance biomarker development.

The partners have established a laboratory to investigate cell-free DNA and other bloodborne molecules as cancer biomarkers.

The financing will support business expansion, continued technology development, and expenses related to a planned listing at the end of the year.

The findings support the neural crest hypothesis of domestication, which says common changes seen in domesticated animals are due to developmental alterations.

The firm acquired startup HumanCode, which had developed genetic testing apps around ancestry and wellness for the Helix platform.

The court's ruling that Quest was acting as a licensed healthcare provider could affect the statute of limitations in the suit.

The company said it will use the funding to accelerate the development of an affordable sequencing test for metagenomic samples.

An international research team uncovered differences in both host and parasite gene expression between uncomplicated and severe malaria cases in The Gambia.

Using data from the UK Biobank, researchers explored relative contributions that genetics and lifestyle make to cardiovascular disease and diabetes risk.

The new assay simultaneously detects four viral targets in donated blood plasma in a single sample and can add value to the biologics development space.

With genome sequences or genotyping profiles for 280 Native American and mestizo individuals, researchers explored population history and dynamics in Peru.

The subcommittee called for $2 billion to be added to the NIH's budget next year, increasing it to $39.1 billion.

Using samples from obese women with hepatic steatosis, investigators uncovered ties between the condition, gut microbes, metabolites, and liver gene expression.

Clearbridge will refer its patients to Genome.One's GoExplore test for disease risk assessment and drug response prediction.

Researchers reported that natural killer cells produce a cytokine that recruits stimulatory dendritic cells to the tumor to boost patients' response to T-cell-based immunotherapies.

The firm will use the funds to develop its Singulator system, which uses single-use sample cartridges and reagents to rapidly isolate cells and nuclei.

NeoGenomics has now redeemed 100 percent of the $110 million preferred stock issues in conjunction with the Clarient acquisition, at a cost of $105 million.

Bio-Techne will pay $250 million in cash, as well as up to an additional $325 million contingent on the achievement of certain milestones.

The researchers also reported that cholera strains infecting members of the same household were highly similar, suggesting in-household transmissions.

DNAstack will help Autism Speaks add a data discovery portal and data-sharing features to the research platform, and integrate it with bioinformatics workflows.

The companies are creating a new center that will offer support services to biopharmaceutical companies, CROs, and others in designing genetically informed clinical trials.

Two new studies have uncovered expression-defined T cell subsets that seem to coincide with better or worse outcomes in breast cancer or non-small cell lung cancer.

Pages

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.